Biotech

All Articles

ArsenalBio increases $325M, turns away from previous lead asset

.Toolbox Biosciences is moving on up. The tissue therapy company has actually added $325 million in ...

Lilly- supported weight reduction biotech documents IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has filed to ...

Aelis' cannabis usage medicine fails phase 2b, driving Indivior to rethink $100M choice

.Aelis Farma's hopes of protecting a simple, good selection on a $100 thousand alternative settlemen...

ProKidney stops period 3 test certainly not required for tissue therapy authorization

.ProKidney has ceased some of a set of stage 3 tests for its own cell treatment for kidney health co...

Vaxcyte climbs on 'magnificent' 31-valent PCV gain against Pfizer

.Vaxcyte revealed what professionals referred to as "stunning" stage 1/2 data for its 31-valent pneu...

Recursion's mind condition test presents insufficient evidence of efficacy

.Recursion has actually stumbled via an early examination of its own tech-enabled strategy to drug r...

Acepodia, Pfizer click on together for chemistry-based tissue therapy

.Contact it a scenario of really good chemical make up: Acepodia, a biotech based on Nobel Prize-win...

Praxis epilepsy medication lessens seizures in period 2 litigation

.Practice Preciseness Medicines has racked up an additional midphase succeed in epilepsy this year, ...

Three directors surrender as Dyne articles mixed data for DMD prospect

.After escaping a medical hold a number of years back, Dyne Therapeutics has actually revealed brand...

Arrowhead fires off phase 3 data in unusual metabolic health condition in front of market clash with Ionis

.Arrowhead Pharmaceuticals has actually presented its hand in front of a prospective face-off along ...